Abstract
In the treatment of hypertension fast onset of action is the major concern. The problem of slow onset of action of drugs can be overcome by development of appropriate dosage forms. Fast disintegrating tablets in mouth are best suited and have gained popularity in the oral antihypertensive drug therapy. These are advantageous over other conventional systems in terms of patient compliance, rapid onset of action, accurate dosing, good chemical stability, convenience of self- administration and compactness. Losartan potassium is widely used as an antihypertensive drug, which is a potent drug candidate for developing in to Fast Dissolving Tablets (FDT’s). It has low bioavailability due to first pass metabolism. Hence the main objective of the study was to formulate fast dissolving tablets of Losartan potassium to achieve a better dissolution rate and further improving the bioavailability of the drug. Fast dissolving tablet of Losartan potassium were formulated by using microcrystalline cellulose with different concentration of superdisintegrants like sodium starch glycolate and Isabgol Mucilage. All the batches were prepared by direct compression.
API characterization studies were conducted to check the purity of API .The tablets were evaluated for Pre compression parameters and post compression parameters. Before the formulation of the tablets IR spectroscopic studies were also performed to check the compatibility with the excipients.
A 23 full factorial design was applied to investigate the combine effect of 3 formulation variables. Here the concentration of Isabgol mucilage, concentration of Sodium Starch Glycolate and concentration of Microcrystalline Cellulose were taken as independent variable X1, X2 & X3 respectively and their effect of disintegration time is studied as dependent parameter. To represent the data Design Expert software is used.
References
Lachman L, Lieberman H.A., Kanig J.L. The theory and practice of industrial pharmacy 3rd edition Mumbai: Varghese Publishing House; 1987; 182‐184.
Staniforth J.N., Aulton M.E. Powder flow In: Alton’s Pharmaceutics: the design and manufacturing of medicines. 3rd ed. Hungary: Harcourt publisher ltd.2007; 175‐79.
Ansel H.C., Popovich NG, Allen LV. Pharmaceutical dosage forms and drug delivery system. 8th ed. New Delhi. B. I. Waverly Pvt. Ltd. 1995;189‐94, 235‐36.
Martin A. Diffusion and Dissolution. In: Physical pharmacy.3rd ed.Philadelphia: Lea and Febiger; 1983; 399‐444. MA Tahir, K Awadhesh, S Swati, S Sant, MA Sajid, GD Pattnaik, Farheen. Optimization Of Fast Disintegrating Tablets For Diclofenac Sodium Using Isabgol Mucilage As Super Disintegrant. International Journal of Pharmaceutical Sciences INT.J.PH.SCI.,MAY- AUG, 2010;2(2):496-501 ISSN 0975-4725
Rakesh Pahwa, Mona Piplani, Vipin Kumar Garg, Rekha Rao and H.S.Lamba. Formulation and Evaluation of Orally Disintegrating Tablets: Comparison of Natural and Synthetic Superdisintegrants. Scholars Research Library Der Pharmacia Lettre, 2011, 3(2): 407-418 ISSN 0975-5071 USA CODEN: DPLEB4
Debjit Bhowmik, Chiranjib.B, Jyoti jaiswal,Vinod dubey, Margret Chandira.Fast dissolving tablet: A review on revolution of novel drug delivery system and new market opportunities.der pharmacia let 2009;1(2):262- 276
V. N. Deshmukh. Mouth Dissolving Drug Delivery System: A Review. Int J PharmTech Res 2012;4(1):412-421
P. Ashish, M.S. Harsoliya, J.K.Pathan, S. Shruti. A Review- Formulation of Mouth Dissolving tablet.Int J
Pharm Clin Sci 2011; 1 (1): 1-8
Tejvir Kaur, Bhawandeep Gill, Sandeep Kumar, G.D. Gupta. Mouth dissolving tablets: A Novel approach to drug delivery. Int J Pharml Res 2011;3(1):1-7
Sagar A. Konapure, Prafulla S. Chaudhari, Rajesh J. Oswal, Sandip S. Kshirsagar, Rishikesh V. Antre, Trushal
V. Chorage. Mouth dissolving tablets” an innovative technology. Int J App Bio And Pharma Sci 2011;1(2):496-503
Tarique Khan, Sayyed Nazim, Siraj Shaikh, Afsar Shaikh, Ashish Khairnar, Aejaz Ahmed. An Approach for rapid disintegrating tablet: A review. Int J Pharma Res Dev ,2011;3(3):170 – 183
Devesh A. Bhatt , Smita I. Rane “Qbd Approach To Analytical Rphpl Method Development And Its Validation” International Journal of Pharmacy and Pharmaceutical Sciences ISSN- 0975-1491 Vol 3, Issue 1, 2011
Example QbD IR Tablet Module 3 Quality 3.2.P.2 Pharmaceutical Development April 2012
Using Quality by Design (QbD) in Designing Efficient, FDA Compliant Pharmaceutical Manufacturing Processes and FacilitiesWhat is the Impact? by Russ Somma, Ph.D.SommaTech, LLC
Biostatistics A Methodology for the Health Sciences Second Edition Gerald Van Belle, Lloyd D. Fisher, Patrick J. Heagerty, Thomas Lumley. A John Wiley & Sons, Inc., Publication.
Design and Analysis of Experiments Volume 2 Advanced Experimental Design by Klaus Hinkelmann, Oscar Kempthorne . A John Wiley & Sons, Inc., Publication.
Research Design and Statistical Analysis Second Edition by Jerome L. Myers, Arnold D. Well. Lawrence Erlbaum Associates, Publishers 2003 Mahwah, New Jersey London
Pharmaceutical Experimental Design and Interpretation by N. Anthony Armstrong. Second Edition. Published in 2006 by CRC Press Taylor & Francis Group.
Q8 PharmaceuticalDevelopment : ICH guidelines
Q9 Quality Risk Management: ICH guidelines
Q10 Pharmaceutical Quality System : ICH guidelines
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Copyright (c) 2020 Array